PDL BioPharma (PDLI) Declares $0.05 Quarterly Dividend; 6.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
PDL BioPharma Announces First Quarter 2016 Financial Results
May 4, 2016 4:02 PM EDT
INCLINE VILLAGE, Nev., May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2016 including:
Total revenues of $103.1 million for the first quarter of 2016. Non-GAAP diluted earnings per share (EPS) of $0.52 increased approximately 11 percent versus the same period in 2015. Non-GAAP net income increased 7 percent to $84.8 million. GAAP diluted EPS of $0.34 decreased by 32 percent compared to the same period of 2015. GAAP net income decreased by 34 percent to $55.9 million.The... More
PDL BioPharma Announces 2016 Second Quarter Dividend
May 4, 2016 4:01 PM EDTINCLINE VILLAGE, Nev., May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that its board of directors has declared a $0.05 per share dividend for the second quarter of 2016. The cash dividend will be paid on June 13, 2016 to all stockholders who own shares of PDL on June 6, 2016, the record date for the second quarter dividend payment.
Stockholders desiring to purchase shares with rights to the dividend must ensure that their trades are executed prior to the "ex-dividend" date and settled prior to the record date. NASDAQ generally... More
